While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

We are always amused that we can run emulations or virtual copies of yesterday’s computers on our modern computers. In fact, there is so much power at your command now that you can run, say, ...

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

American Airlines quietly ended the ability for customers traveling on basic economy tickets to earn miles and status. Basic economy tickets are airlines' most restrictive and already do not allow for ...

UBI provides regular, unconditional cash payments to individuals without work requirements. Largest UBI trial in Kenya improved medical access and business startup rates. UBI's high cost and potential ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Dr. Berg teaches philosophy at the University of California, Irvine. Last spring, it became clear to me that over half the students in my large general education lecture course had used artificial ...

AI is making ever more jobs obsolete. The solution from Silicon Valley? A universal paycheck, no work required. Technology titans including Elon Musk and Sam Altman see a future flush with wealth ...